Burant C F, Treutelaar M K, Buse M G
Department of Medicine, Medical University of South Carolina, Charleston 29425.
Endocrinology. 1988 Feb;122(2):427-37. doi: 10.1210/endo-122-2-427.
We have recently described structural differences between insulin receptors isolated from rat skeletal muscle and liver. In this report we compared their intrinsic kinase activity and their precipitability with antiphosphotyrosine and polyclonal anti-beta-subunit antibodies before and after stimulation by insulin in vitro or in vivo. Liver derived receptors incubated with insulin showed 40-50% less autophosphorylation and exogenous substrate tyrosine kinase activity per insulin binding site than those from muscle, as well as a 50% reduction in the proportion of antiphosphotyrosine precipitable receptors. After tyrosine kinase was maximally activated by iv insulin injection (in vivo), antiphosphotyrosine antibodies precipitated 60% and 38% of insulin receptors from muscle and liver, respectively. Addition of insulin in vitro to in vivo activated receptors increased the proportion of antiphosphotyrosine antibody-precipitable receptors in both tissues but increased the tyrosine kinase activity only in liver-derived receptors, indicating that most activatable insulin receptors reside on the plasmalemma in muscle whereas a significant proportion (35%) of liver receptors are not accessible to insulin in vivo. No tissue specific differences were apparent in the interaction of three site specific anti-beta-subunit antibodies with the receptors.
我们最近描述了从大鼠骨骼肌和肝脏分离的胰岛素受体之间的结构差异。在本报告中,我们比较了它们在体外或体内胰岛素刺激前后的内在激酶活性,以及它们与抗磷酸酪氨酸和多克隆抗β亚基抗体的沉淀性。与胰岛素孵育的肝脏来源的受体,每个胰岛素结合位点的自磷酸化和外源性底物酪氨酸激酶活性比肌肉来源的受体低40 - 50%,抗磷酸酪氨酸可沉淀受体的比例也降低了50%。静脉注射胰岛素(体内)使酪氨酸激酶最大程度激活后,抗磷酸酪氨酸抗体分别沉淀了来自肌肉和肝脏的60%和38%的胰岛素受体。在体外向体内激活的受体中添加胰岛素,增加了两个组织中抗磷酸酪氨酸抗体可沉淀受体的比例,但仅增加了肝脏来源受体的酪氨酸激酶活性,这表明大多数可激活的胰岛素受体位于肌肉的质膜上,而相当比例(35%)的肝脏受体在体内无法被胰岛素作用。三种位点特异性抗β亚基抗体与受体的相互作用没有明显的组织特异性差异。
1)每个胰岛素结合位点的内在激酶活性在肝脏中比在肌肉中低。这部分反映了肝脏中胰岛素受体的更大比例在胰岛素结合后不会在酪氨酸上进行自磷酸化。2)一些胰岛素受体在体外可以在酪氨酸上磷酸化,而无需伴随外源性酪氨酸激酶激活。